KIORA PHARMACEUTICALS, INC. Restricted Cash and Cash Equivalents, Noncurrent
KIORA PHARMACEUTICALS, INC. (KPRX) had Restricted Cash and Cash Equivalents, Noncurrent of $4.71 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-07
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $4.71K.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $4.69K.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $4.57K.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $4.52K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $4.71K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.69K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $4.57K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $4.52K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $4.46K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.08K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $4.06K 10-K · filed 2026-03-25 |
| 2024-09-30 | $4.52K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.18K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $4.08K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $4.27K 10-K · filed 2025-03-25 |
| 2023-09-30 | $4.03K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.15K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.18K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $49.26K 10-K · filed 2024-03-25 |
| 2022-09-30 | $49.04K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $49.31K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $45.00K 10-Q · filed 2022-07-08 |
| 2021-12-31 | $45.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $45.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $45.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $45.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $45.00K 10-K/A · filed 2022-07-07 |
| 2020-09-30 | $45.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $45.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $45.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $45.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $45.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $45.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $45.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $45.00K 10-K · filed 2020-03-04 |
| 2018-09-30 | $45.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $45.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $45.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $45.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $45.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $45.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $45.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $45.00K 10-K · filed 2018-03-02 |
| 2016-09-30 | $45.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $45.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $30.00K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $20.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $20.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $20.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $20.00K 10-Q · filed 2015-05-18 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |